国药龙立品牌怎么样 申请店铺

更新时间:2024-10-28
国药龙立是哪个国家的品牌?「国药龙立」是 北京新龙立科技有限公司 旗下著名品牌。该品牌发源于北京,由创始人张海良在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
国药龙立怎么样


北京国药龙立科技有限公司成立于1996年6月,是隶属于中关村科技园区的高新技术企业,中国制药机械行业协会副理事长单位,主要从事制药装备的技术开发、生产制造、营销及维修服务。1998年,公司主要产品GZPL系列高速压片机被北京市列入重大科技成果推广计划,并于1999年获北京市科技进步三等奖。2003年GZPL系列高速压片机获得了方圆认证中心的“产品质量认证证书”,并于2004年获得了德国莱茵公司的“CE认证证书”。2004年,公司开发的GZPL-620系列高速压片机项目被列入“国家火炬计划”;2005年,该项目被列入"国家级重点火炬计划项目"。

公司建立了规范的法人治理结构,并具备一整套与现代企业制度相适应的内部管理机制。公司已在浙江、南京等地建立了4家子公司,员工260余人,资产总额超过8000万元。公司的研发中心拥有三十余名经验丰富的专家和人才,拥有较强的自主开发能力,累计获得实用新型专利7项,发明专利8项,继完成《高速压片冲模》行业标准的制定之后,承担起草《高速旋转式压片机》国家标准的任务。公司积极探索产学研合作模式,与华中理工大学合作开发高速压片机电脑控制系统,提升了产品的操作性;与国家中药现代化工程研究中心合作建立中药超微粉碎技术研发基地;与天津大学合作研究模具新材料的应用。公司于2001年3月在药机行业率先通过了ISO9001质量体系认证,2003年4月公司又通过了方圆标志认证中心的ISO9001:2000质量体系转版认证。

公司主导产品为各系列高速压片机及辅机、模具,各种型号单冲机、台式机和特种压片机,系列干法制粒机、整粒机,各系列超微粉碎机和微粉粉碎机;公司代理销售世界一流的药品检测设备;产品应用领域从制药行业逐步向生物、化工、食品等行业延伸。据统计,从公司成立以来累计销售各类设备3000余台,其中销售高速压片机600余台,在国内高速压片机的市场占有率已经超过了50%,并已实现产品替代进口,公司的主要产品出口到欧美、东南亚、俄罗斯、东欧等国家。

公司拥有完善的区域性销售服务网络,良好的销售团队和售后服务队伍为用户提供优质的售前、售中和售后服务。同时公司通过CRM系统对客户管理实现了信息化管理。

2007年公司投资4000多万元人民币在北京大兴生物与医药产业基地建成了占地30亩的总部基地,建有综合研发楼、中试车间、制药装备车间及配套设施等总建筑面积15899平方米。

公司一贯重视人才,积极引进研发、生产、销售和管理人员,建立了长期和短期相结合的奖励机制,创造各种条件鼓励员工学习,定期开展各种专业培训,建有专门的图书阅览室、上网室;在文化生活方面创建各种交流和沟通渠道,包括网站论坛、企业内刊、公司领导接待日等,定期组织员工联欢活动、员工体检,投资兴建职工餐厅、篮球场、娱乐室、乒乓球室,丰富了员工业余文化生活,提倡健康生活,快乐工作,增强了公司凝聚力。


Founded in June 1996, Beijing Guoyao Longli Technology Co., Ltd. is a high-tech enterprise affiliated to ZhongGuanCun science and Technology Park and vice president unit of China Pharmaceutical Machinery Industry Association, mainly engaged in the technical development, production and manufacturing, marketing and maintenance services of pharmaceutical equipment. In 1998, the company's main product, gzpl series high-speed tablet press, was listed in the promotion plan of major scientific and technological achievements by Beijing, and won the third prize of Beijing scientific and technological progress in 1999. In 2003, gzpl series high-speed tablet press obtained the "product quality certificate" of Fangyuan Certification Center and the "CE certificate" of German Rhine company in 2004. In 2004, the gzpl-620 series high-speed tablet press project developed by the company was listed in the "National Torch Plan"; in 2005, the project was listed in the "national key torch plan project". The company has established a standardized corporate governance structure, and has a set of internal management mechanism which is suitable for the modern enterprise system. The company has established 4 subsidiaries in Zhejiang, Nanjing and other places, with more than 260 employees and total assets of more than 80 million yuan. The R & D center of the company has more than 30 experienced experts and talents, has strong independent development ability, and has obtained 7 utility model patents and 8 invention patents. After completing the formulation of the industry standard of high speed tablet pressing die, it undertakes the task of drafting the national standard of high speed rotary tablet press. The company actively explored the mode of production university research cooperation, cooperated with Huazhong University of science and technology to develop the computer control system of high-speed tablet press, which improved the operability of the product; cooperated with the national modernization Engineering Research Center of traditional Chinese medicine to establish the research and development base of ultra micro pulverization technology of traditional Chinese medicine; cooperated with Tianjin University to study the application of new mold materials. In March 2001, the company first passed the ISO9001 quality system certification in the pharmaceutical machinery industry, and in April 2003, the company passed the ISO9001:2000 quality system version transfer certification of Fangyuan Mark Certification Center. The company's leading products are various series of high-speed tablet presses, auxiliary machines and molds, various models of single punch machines, desktops and special tablet presses, series of dry process granulators, pelletizers, various series of ultra micro pulverizers and micro pulverizers; the company's agent sales of world-class pharmaceutical testing equipment; the product application field gradually extends from the pharmaceutical industry to the biological, chemical, food and other industries. According to statistics, since the establishment of the company, the company has sold more than 3000 sets of various equipment, including more than 600 sets of high-speed tablet presses. The market share of high-speed tablet presses in China has exceeded 50%, and the company has realized the substitution of products for imports. The company's main products are exported to Europe, America, Southeast Asia, Russia, Eastern Europe and other countries. The company has a perfect regional sales service network, a good sales team and after-sales service team to provide users with high-quality pre-sales, sales and after-sales services. At the same time, the company realizes the information management of customer management through CRM system. In 2007, the company invested more than 40 million yuan to build a headquarters base covering an area of 30 mu in Beijing Daxing biological and pharmaceutical industry base, with a total construction area of 15899 square meters, including comprehensive R & D building, pilot plant, pharmaceutical equipment workshop and supporting facilities. The company has always attached great importance to talents, actively introduced R & D, production, sales and management personnel, established a long-term and short-term incentive mechanism, created various conditions to encourage employees to learn, regularly carried out various professional training, and built a special book reading room and Internet room; and created various communication channels in cultural life, including website forum, enterprise journal, and the company Leaders' reception days, etc., regularly organized staff get-together activities, staff physical examination, invested in the construction of staff restaurant, basketball court, entertainment room, table tennis room, enriched the staff's amateur cultural life, advocated healthy life, happy work, and enhanced the company's cohesion.

本文链接: https://brand.waitui.com/331f6b23a.html 联系电话:010-61253338

千城特选小程序码

7×24h 快讯

中央汇金三季度继续出手,3000亿元增持五大宽基ETF

最新披露的基金2024年三季报证实,在三季度的震荡行情中,中央汇金资产管理有限责任公司(下称“中央汇金”)继续增持ETF,仅4只沪深300ETF和华夏上证50ETF,就耗资约3000亿元。从年内的资金流向来看,大量资金借道ETF入市,ETF净申购额接近8800亿元,仅华泰柏瑞沪深300ETF净申购额就高达2002亿元。(上证报)

24分钟前

氧化铝价格创近十年新高,供给收紧局面难改

自10月22日盘中一度突破5000元/吨关口后,国内期货市场上氧化铝主力合约2411价格近日已稳定在5100元/吨上方,刷新历史高点,较一年前这一新品种上市之初的价格近乎翻番。而现货市场上,当前氧化铝价格也已逼近5000元/吨,为近十余年来高位。作为电解铝重要的生产原材料,氧化铝价格持续走高,已显著冲击了铝企的盈利水平。相较今年5月份,铝企单吨盈利已缩减超千元,个别企业甚至陷入亏损区间。氧化铝价格高位运行,对下游形成冲击,产业链负反馈效应渐显。不过分析人士多认为,当前氧化铝供给端未释放预期,市场供需矛盾尚存,短期价格强势格局或难改。(证券时报)

25分钟前

逾800家公司披露股东回报规划,稳步提升A股估值

近期,A股公司分红积极性持续高涨,分红金额屡创新高。统计发现,今年合计已有813家公司披露了三年股东回报规划并锁定最低分红率,为近四年来最多。年化估算预计将有957家公司披露最低分红方案,有望刷新年度历史最高纪录。同时,大量龙头公司展现出引领风范。数据显示,今年以来已经有4家千亿市值公司披露了未来三年每年不低于30%分红率的股东回报规划,此前五年合计只有3家千亿市值公司披露了类似承诺。发布股东回报规划的上市公司数量大幅增长,表明A股分红透明度进一步加大,有助于稳步提升A股估值。(证券时报)

25分钟前

波音公司据悉计划最快在周一将进行超过150亿美元融资

波音公司计划最快在周一将进行超过150亿美元的融资。(财联社)

25分钟前

自营业务驱动,多数券商三季度业绩回暖

10月25日,东方财富、湘财股份、国元证券、国盛金控等上市券商及上市券商主体纷纷发布三季度“成绩单”。10月23日,首创证券披露首份券商三季报。总体来看,首批券商三季报业绩出现分化,有的前三季度营收净利润双双实现同比正增长,有的业绩小幅下滑。不过,多数券商第三季度业绩普遍回暖。分业务来看,自营业务仍是券商业绩增长主要驱动因素,如东方财富、首创证券等自营业务均实现同比增长。(上证报)

25分钟前

本页详细列出关于国药龙立的品牌信息,含品牌所属公司介绍,国药龙立所处行业的品牌地位及优势。
咨询